C81.2 Mixed cellularity Hodgkin lymphoma

⚠ Non-Billable ICD-10-CM 2026
Open C81.2 in Web App →

The ICD-10-CM code for Mixed cellularity Hodgkin lymphoma is C81.2 (FY2026). It is a non-billable category code — select a more specific code below for claims.

Classification

Section
C81-C96: Malignant neoplasms of lymphoid, hematopoietic and related tissue (C81-C96)
Category C81
85 codes (77 billable)
FY2026 Status
Stable since FY2024

Also Known As

ICD-10-CM Alphabetic Index entries that lead to C81.2:

  • Lymphoma (of) (malignant) › Hodgkin › mixed cellularity classical
  • Lymphoma (of) (malignant) › Hodgkin › mixed cellularity (classical)

Inclusion Terms

  • Mixed cellularity classical Hodgkin lymphoma

Official Coding Guidelines

Metastatic lymphoid malignancy—use C81-C85 extranodal site code

t. Secondary malignant neoplasm of lymphoid tissue When a malignant neoplasm of lymphoid tissue metastasizes beyond the lymph nodes, a code from categories C81-C85 with a final character identifying “extranodal and solid organ sites” should be assigned rather than a code for the secondary neoplasm of the affected solid organ. For example, for metastasis of diffuse large B-cell lymphoma to the lung, brain and left adrenal gland, assign code C83.398, Diffuse large B-cell lymphoma of other extranodal and solid organ sites.

— ICD-10-CM Official Guidelines for Coding and Reporting, FY2026, Section I.C.2.t
Tx of primary site (TOC entry)

a. Admission/Encounter for treatment of primary site ............................................................. 33

— ICD-10-CM Official Guidelines for Coding and Reporting, FY2026, Section I.C.2.a

Source: CMS — ICD-10-CM Official Guidelines for Coding and Reporting, FY2026

References

Related Codes

Parent Code

C81 Hodgkin lymphoma

More Specific Codes

Related Codes in C81

Search all 70,000+ ICD-10-CM codes →
Reviewed by Prajwal Shrestha, CPC, CRC
Certified Professional Coder (CPC) and Certified Risk Adjustment Coder (CRC) · AAPC Member ID 01997614 · About · Editorial policy · Content last reviewed: 2025-10-01

Get HCC Mappings, Clinical Summaries, and More

Access premium features including HCC risk adjustment, FDA drug indications, AI coding assistant, and comprehensive clinical context.

Start Free Trial